Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)

PSA screening reduces PCa-mortality but the disadvantages overdiagnosis and overtreatment require multivariable risk-prediction tools to select appropriate treatment or active surveillance. This review explains the differences between the two largest screening trials and discusses the drawbacks of s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EJIFCC
Hauptverfasser: Stephan, Carsten, Rittenhouse, Harry, Hu, Xinhai, Cammann, Henning, Jung, Klaus
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Communications and Publications Division (CPD) of the IFCC 2014
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4975191/
https://ncbi.nlm.nih.gov/pubmed/27683457
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge